Clinical Trials Sponsored by Kyoto Breast Cancer Research Network

Total 814 results

Kyoto Breast Cancer Research Network

Completed

Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer

Breast Cancer

Japan
Kyoto Breast Cancer Research Network

Terminated

Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer

Breast Cancer

Japan
Kyoto Breast Cancer Research Network
Pfizer

Completed

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female

Taiwan, Japan, Korea, Republic of, Australia, Hong Kong
Translational Research Center for Medical Innovation...
Kyoto Breast Cancer Research Network

Completed

Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer (E-SPEC)

Breast Cancer

Japan
Japan Breast Cancer Research Network

Completed

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

Breast Neoplasms

Japan
Japan Breast Cancer Research Network

Terminated

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

Breast Neoplasms

Japan
International Breast Cancer Research Foundation
Breast Cancer Research Foundation

Completed

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Breast Cancer

United States, China, Bangladesh, Nigeria, Philippines, Morocco, India, Indonesia, Malaysia, Vietnam
M.D. Anderson Cancer Center
Inflammatory Breast Cancer Network Foundation

Terminated

Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter

Breast Cancer

United States
University Health Network, Toronto
Canadian Breast Cancer Research Alliance

Completed

Effects of Exemestane on Bone Strength (MAP3BSS)

Breast Cancer | Osteoporosis

United States, Canada
Abramson Cancer Center of the University of Pennsylvania
Pfizer; Hoosier Cancer Research Network; Translational Breast Cancer Research... and other collaborators

Withdrawn

Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") (GLACIER)

Breast Cancer

United States
Baylor Breast Care Center
GlaxoSmithKline; Translational Breast Cancer Research Consortium

Active, not recruiting

Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy (HELEX)

Breast Cancer

United States
Ontario Clinical Oncology Group (OCOG)
Canadian Breast Cancer Research Alliance; Ontario Cancer Research Network

Completed

Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)

Metastatic Breast Cancer | Recurrent Breast Cancer

Canada
M.D. Anderson Cancer Center
Breast Cancer Research Foundation

Completed

Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer

Breast Cancer

United States, Mexico, Peru, Spain
Ontario Clinical Oncology Group (OCOG)
Canadian Breast Cancer Research Alliance; Ontario Cancer Research Network

Completed

Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe) (AdHERe)

Metastatic Breast Cancer
SOLTI Breast Cancer Research Group

Recruiting

Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer. (RADIOLA)

Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast Cancer

Spain
SOLTI Breast Cancer Research Group

Terminated

Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer (NEREA)

Breast Cancer

Spain, Portugal
Jonsson Comprehensive Cancer Center
Breast Cancer Research Foundation

Completed

Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors

Breast Cancer

United States
Spanish Breast Cancer Research Group

Active, not recruiting

Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer (NIKOLE)

Metastatic Breast Cancer

Spain
Spanish Breast Cancer Research Group

Completed

Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer (ChangHER-SC)

Breast Cancer

Spain
SOLTI Breast Cancer Research Group

Completed

SOLTI Breast Cancer Molecular Screening Program (AGATA) (AGATA)

Metastatic Breast Cancer

Spain
Sanofi
Breast Cancer Research Foundation

Completed

A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer

Triple Negative Breast Cancer

United States
University Health Network, Toronto
Canadian Breast Cancer Foundation

Completed

Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect (SuBDuE)

Metastatic Breast Cancer With Bone Involvement

Canada
Fred Hutchinson Cancer Center
Breast Cancer Research Foundation

Recruiting

Acute Exercise Intervention in Breast Cancer Survivors (ACE)

Breast Carcinoma

United States
Fred Hutchinson Cancer Center
Breast Cancer Research Foundation

Completed

Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
Fred Hutchinson Cancer Center
Breast Cancer Research Foundation

Completed

Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants

Healthy Subject

United States
Jonsson Comprehensive Cancer Center
Susan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation

Completed

Project Connect Online: An Internet-based Intervention for Women With Breast Cancer (PCO)

Breast Neoplasms

United States
SOLTI Breast Cancer Research Group

Not yet recruiting

HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan (ACROSS-TROP2)

Breast Cancer Stage IV

Spain
SOLTI Breast Cancer Research Group

Recruiting

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer (SOLTI-2104)

Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast Cancer

Spain
Spanish Breast Cancer Research Group

Recruiting

Registry Study of Pregnancy and Breast Cancer (EMBARCAM)

Breast Cancer and Pregnancy

Spain
SOLTI Breast Cancer Research Group

Completed

Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer (PATRICIA II)

Metastatic Breast Cancer

Spain
SOLTI Breast Cancer Research Group

Terminated

Targeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic BC (ARIANNA)

Breast Cancer

Spain
SOLTI Breast Cancer Research Group

Completed

Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer (ONAWA)

Breast Cancer

Spain
SOLTI Breast Cancer Research Group

Completed

Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer (Opti-HER)

Breast Cancer

Spain
International Breast Cancer Research Foundation

Completed

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Breast Cancer

Philippines, Morocco, Vietnam
University Health Network, Toronto
Canadian Breast Cancer Foundation

Completed

Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:Protocol (iMOVE)

Breast Neoplasms

Canada
Hamilton Health Sciences Corporation
McMaster University; Canadian Breast Cancer Research Alliance; Ontario Cancer...

Completed

Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2

Breast Neoplasms

Canada
University Health Network, Toronto
Canadian Cancer Trials Group; Canadian Breast Cancer Research Alliance

Completed

RCT of a Group Intervention for Women With a Family History of Breast Cancer

Breast Neoplasms

Canada
UNC Lineberger Comprehensive Cancer Center
Breast Cancer Research Foundation

Completed

The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older (S-PACT)

Cancer | Fatigue | Geriatric

United States
Ozmosis Research Inc.
Breast Cancer Research Foundation

Completed

A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer

Metastatic Breast Cancer

Canada
UNC Lineberger Comprehensive Cancer Center
Breast Cancer Research Foundation

Suspended

LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Breast Cancer Research Foundation

Recruiting

Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Breast Cancer Research Foundation

Completed

The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer

Breast Cancer | Aging

United States
Spanish Breast Cancer Research Group
Sanofi

Completed

Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment

Breast Neoplasms

Spain
Spanish Breast Cancer Research Group
Novartis

Completed

Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients (EDALINE)

Advanced Breast Cancer

Spain
Spanish Breast Cancer Research Group
Novartis

Completed

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Breast Cancer | Neoplasm Metastasis

Spain
Spanish Breast Cancer Research Group
AstraZeneca

Completed

Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer (COMETABreast)

Advanced Breast Cancer

Spain
Indiana University
Breast Cancer Research Foundation

Withdrawn

Breast Cancer BRCA1 Carriers: a Pilot Study

High-grade Serous Ovarian Cancer | BRCA1 Mutation | TNBC - Triple-Negative Breast Cancer

United States
Spanish Breast Cancer Research Group
AstraZeneca

Active, not recruiting

Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer (FLIPPER)

Breast Neoplasms

Spain, Ireland
Spanish Breast Cancer Research Group
Sanofi

Completed

Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients

Breast Cancer

Spain
Stanford University
Susan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation

Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

Breast Cancer | Ovarian Cancer | Gynecologic Cancers | Ovarian/Peritoneal/Fallopian Cancer

United States

Clinical Trials Sponsored by Kyoto Breast Cancer Research Network

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations